Possible Renal Repairing Mechanisms of Mesenchymal Stem Cells in Cyclosporine-Mediated Nephrotoxicity: Endothelial Viability and Hemodynamics

Elshahat Abo-Mosalam Toson, Hanaa Hamdy Ahmed, Hatem Abdel Moneim El-mezayen, Laila Ahmed Rashed, Eslam Samy Elsherbiny

Abstract


BACKGROUND: Stem cell-based therapy may represent the first realistic option for tissue repairing and regeneration. Mesenchymal stem cells (MSCs) are proved to be involved in the regeneration of many tissues which are subjected to different types of injury. Cyclosporine (CsA) in spite of its use as immune suppressive drug during kidney transplantation, it was considered as important model of nephropathy specially, during long-term administration.

METHODS: Isolation and preparation of MSCs using Dulbecco's modified Eagle's medium (DMEM), in vitro differentiation through adipogenesis chondrogenesis and osteogenesis was confirmed by using Alizarin Red S stain, Oil Red O stain and Alcian Blue stain, respectively, characterization using flow cytometry technique to detect cluster of differentiation (CD)34, CD44 and CD105 surface markers and homing of MSCs using polymerase chain reaction (PCR) Sry gene assay, were executed. Serum levels of vascular endothelial growth factor (VEGF), endothelin-1 (ET-1) and endothelial nitric oxide synthase (eNOS) were quantified using enzyme-linked immunosorbent assay (ELISA) kits based on the principle of double-antibody sandwich technique. The structural organization of kidney tissue was examined using histological procedures.

RESULTS: Single intravenous dose of MSCs is capable to boost kidney repairment process as indicated by the significant decrease in serum ET-1 level paralleled by significant increase in VEGF and eNOS. Moreover, histological findings revealed the improvement of focal hemorrhage in between the degenerated tubules, congestion in the cortical blood vessels, vacuolization in the endothelial cells lining the glomerular tufts and focal perivascular inflammatory cells aggregation.

CONCLUSION: This study demonstrated the favorable influence of MSCs in repressing cyclosporine-induced nephropathy in rats. This could be achieved through angiogenic and anti-arteriolopathic mechanisms.

KEYWORDS: angiogenesis, cyclosporine, endothelin-1, MSCs, nephropathy


Full Text:

PDF

References


Busauschina A, Schnuelle P, van der Woude FJ. Cyclosporine Nephrotoxicity. Transplant Proc. 2004; 2: 229S-33S, CrossRef.

Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987; 84: 9265-9, CrossRef.

Sharma SP. Nitric oxide and the kidney. Indian J Nephrol. 2004; 14: 77-84, article.

Perico N, Dadan J, Remuzzi G. Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol. 1990; 1: 76-83, PMID.

Kanesaki Y, Suzuki D, Uehara G, Toyoda M, Katoh T, Sakai H, et al. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis. 2005; 45: 288-94, CrossRef.

Kang D, Nakagawa T, Feng L, Johnson RJ. Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol. 2002; 161: 239-48, CrossRef.

Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol. 2001; 159: 599-608, CrossRef.

Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growthrelated events and synthesis of matrix proteins in renalinterstitial fibroblasts. Kidney Int. 1997; 52: 1497-510, CrossRef.

Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, et al. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. Br J Pharmacol. 2000; 130: 1339-47, CrossRef.

De Girolamo L, Lucarelli E, Alessandri G, Avanzini MA, Bernardo ME, Biagi E, et al. Mesenchymal stem/stromal cells: A new“cells as drugs” paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm. 2013; 19: 2459-73, CrossRef.

Alhadlaq A, Mao JJ. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 2004;13: 436-48, CrossRef.

Tomiyama K, Murase N, Stolz DB, Toyokawa H, O'Donnell DR, Smith DM, et al. Characterization of transplanted GFP+ bone marrow cells into adipose tissue stem cells. 2008; 26: 330-8, CrossRef.

Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003; 17: 160-70, CrossRef.

Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes rates of proliferation and differentiation potential. Blood. 2004; 103: 1662-8, CrossRef.

Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth and differentiation. J Cell Biochem. 1999; 72: 570-85, CrossRef.

Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000; 61: 364-70, CrossRef.

Ahmed HH, Toson EA, El-mezayen HA, Rashed LA, Elsherbiny ES. Role of mesenchymal stem cells versus angiotensin converting enzyme inhibitor in kidney repair. Nephrology. 2017; 22: 531-40, CrossRef.

Li C, Yang CW, Park JH, Lim SW, Sun BK, Jung JY, et al. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Am J Physiol Renal Physiol. 2004; l286: F46-57, CrossRef.

Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, et al. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis. 1997; 29: 254-64, CrossRef.

Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroentrol. 2005; 214: 3431-40, CrossRef.

El Ansary M, Saadi G, Abd El-Hamid SM. Mesenchymal stem cells are a rescue approach for recovery of deteriorating kidney function. Nephrology. 2012; 17: 650-7, CrossRef.

Banchroft JD, Stevens A, Turner DR. Theory and Practice of Histological Techniques. 4rd ed. New York: Churchil Livingstone; 1996, NLMID.

Ahmed HH, Mahdy EE, Shousha WG, Rashed LA, Abdo SM. Potential role of bone marrow derived mesenchymal stem cells with or without injectable calcium phosphate composite in management of osteoporosis in rat model. Int J Pharm Pharm Sci. 2013; 5: 494-504, article.

Ahmed HH, Mahdy EE, Shousha WG, Rashed LA, Abdo SM. Influence of adipose tissue derived mesenchymal stem cells in combination with injectable bone substitute on osteoclastogenesis in osteoporotic rats. J Appl Pharm Sci. 2013; 3: 46-56, CrossRef.

Song JH, Humes HD. Renal cell therapy and beyond. Semin Dial. 2009; 22: 603-9, CrossRef.

Cavaglieri RC, Martini D, Sogayar MC, Noronha IL. Mesenchymal stem cells delivered at the sub capsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc. 2009; 41: 947-51, CrossRef.

Asanuma H, Vanderbrink BA, Campbell MT, Hile KL, Zhang H, Meldrum DR, et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res. 2011; 168: 51-9, CrossRef.

Lee SR, Lee SH, Moon JY, Park JY, Lee D, Lim SJ, et al. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren Fail. 2010; 32: 840-8, CrossRef.

Kelley R, Werdin ES, Bruce AT, Choudhury S, Wallace SM, Ilagan RM, et al. Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am J Physiol Renal Physiol. 2010; 299: F1026-39, CrossRef.

Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. The coagulolytic system and endothelial function in cyclosporine-treated kidney allograft recipients. Transplantation. 1996; 62: 828-30, CrossRef.

Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int. 2000; 57: 1100-6, CrossRef.

Olyaei AJ, De Mattos AM, Bennett WM. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care. 2001; 7: 384-9, CrossRef.

Smith SR, Creech EA, Schaffer AV, Martin LL, Rakhit A, Douglas FL, et al. Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. Kidney Int. 1992; 41: 199-255, CrossRef.

Padi SS, Chopra K. Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol. Nephron. 2002; 92: 685-92, CrossRef.

Jenkins JK, Huang H, Ndebele K, Salahudeen AK. Vitamin E inhibits renal mRNA expression of COX II, HO I, TGF beta, and osteopontin in the rat model of cyclosporine nephrotoxicity. Transplantation. 2001; 71: 331-4, CrossRef.

Au P, Tam J, Fukumura D, Jain RK. Bone marrow derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood. 2008; 111: 4551-8, CrossRef.

Sanz L, Santos-Valle P, Alonso-Camino V, Salas C, Serrano A, Luís Vicario J, et al. Long-term in vivo imaging of human angiogenesis: critical role of bone marrow derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res. 2008; 75: 308-14, CrossRef.

Meirelles LD, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009; 20: 419-27, CrossRef.

Villanueva S, Cespedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol. 2006; 290: R861-70, CrossRef.

Miyamoto K, Kitamoto Y, Tokunaga H, Takeya M, Ezaki T, Imamura T, et al. Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab Invest. 2004; 84: 1126-36, CrossRef.

Bobadilla NA, Gamba G, Tapia E, García-Torres R, Bolio A, LópezZetina P, et al. Role of NO in cyclosporine nephrotoxicity: Effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol. 1998; 274: F791-8, CrossRef.

Zhong Z, Arteel GE, Connor HD, Yin M, Frankenberg MV, Stachlewitz RF, et al. Cyclosporin a increases hypoxia and free radical production in rat kidneys: Prevention by dietary glycine. Am J Physiol. 1998; 275: F595-604, CrossRef.

Amore A, Emancipator SN, Cirina P, Conti G, Ricotti E, Bagheri N, et al. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int. 2000; 57: 1549-59, CrossRef.

Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor induced but not basic fibroblast growth factor induced angiogenesis. J Clin Invest. 1997; 99: 2625-34, CrossRef.

Kashiwagi M, Shinozaki M, Hirakata H, Tamaki K, Hirano T, Tokumoto M, et al. Locally activated renin-angiotensin system associated with TGF-β1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol. 2000; 11: 616-24, PMID.

Shihab FS, Yi H, Bennett WM, Andoh TF. Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int. 2000; 58: 1174-85, CrossRef.

Islam M, Burke JF Jr, McGowan TA, Zhu Y, Dunn SR, McCue P, et al. Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction. Kidney Int. 2001; 59: 498-506, CrossRef.

DimmelerS, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res. 1997; 81: 970-6, CrossRef.

Dell K, Bohler T, Gaedeke J, Budde K, Neumayer HH, Waiser J. Impact of PGE1 on cyclosporine A induced up-regulation of TGFbeta1, its receptors, and related matrix production in cultured mesangial cells. Cytokine. 2003; 22: 189-93, CrossRef.




DOI: https://doi.org/10.18585/inabj.v11i2.617

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute